- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 13, 2025 | 218.32M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $4.29M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $164.81K |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $766.11K |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $732.42K |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $1.64M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.68M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $4.53M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $664.78K |
| Total Assets | Q1 2025 · Mar 31, 2025 | $5.93M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $2.07M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$1.54M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | −$26.52K |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $1.62M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | $0.00 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | $0.00 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $2.32M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $80.78K |
| Net Income | Q1 2025 · Mar 31, 2024 | −$2.61M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$2.61M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | −$140.2K |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $274.43K |
| Revenue | Q1 2025 · Mar 31, 2024 | $134.24K |